House of Lords Business
Show full summary

Lord Alton of Liverpool to ask Her Majesty's Government, further to the Written Answer by Lord Kamall on 2 November (HL3362), what were the affected genes in the mitochondrial genome and the associated mutations in each of the 24 patients licensed as eligible for mitochondrial replacement treatment; and on what dates each corresponding application was approved by the Human Fertilisation and Embryology Authority.  HL4059

Question HL4059: tabled on 16 November 2021 and due for answer by 30 November 2021

This type of business sits within the Questions & Statements category.

This question has been answered by the relevant Government Department.

Question text

Lord Alton of Liverpool to ask Her Majesty's Government, further to the Written Answer by Lord Kamall on 2 November (HL3362), what were the affected genes in the mitochondrial genome and the associated mutations in each of the 24 patients licensed as eligible for mitochondrial replacement treatment; and on what dates each corresponding application was approved by the Human Fertilisation and Embryology Authority.  HL4059
Legend for business item text
† Item that is new or altered.
* Item is an oral question.
Numbers starting HL are unique identifiers for written questions, Bills or papers.

Member's Registered Interests

There are no interests to show.

Main Member

Lord Alton of Liverpool
Crossbench
Life peer